Real-time enrollment status for this alport syndrome clinical trial
Current Status
Recruiting
Checked: August 28, 2026 at 10:38 AM UTC
| NCT Number | NCT07211685 |
| Recruiting Status | Recruiting |
| Condition | Alport Syndrome |
| Phase | PHASE2 |
| Target Enrollment | 60 participants |
| Active Locations | 6 sites in the US |
| Sponsor | Bayer |
| Last Updated on CT.gov | August 20, 2026 (1 week ago) |
As of August 28, 2026: Clinical trial NCT07211685 is currently recruiting participants. This phase2 study for alport syndrome is actively seeking new participants at 6 locations across the United States. The study is sponsored by Bayer. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT07211685 is actively recruiting participants as of August 28, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 6 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT07211685 was last updated 1 week ago (August 20, 2026). HelloStudys verifies this status automatically.